Effect of Unani formula in Rhinitis (Nazla wa Zukam)

Effect of Lauq Sapistan Khyar Shambari in secondary prevention of Nazla wa Zukam

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052991

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J399- Disease of upper respiratory tract, unspecified

Interventions

Intervention1: Lauq Sapistan Khyar Shambari: A compound Unani formulation Intervention2: Lauq sapistankhyar shambari: A compound Unani formulation Intervention3: Lauq Sapiatan Khyar Shambari: 10 gm. g

Eligibility

Inclusion criteria

Inclusion criteria: 1. All genders, aged between 20 â?? 60 years 2. Patients with combination of more than three of following symptoms of URT: Cough, Sore throat, Runny nose, Nasal congestion, Headache, Low-grade fever, Sneezing, Tearing & Itchy eyes 3. Patients who have agreed to sign the informed consent form and follow up the protocol 4. Patient showing positive finding in PNS Xray

Exclusion criteria

Exclusion criteria: 1. Type 2 DM. 2. Pregnancy & Lactation 3. Patients suffering from acute diarrhea and dysentery or chronic GIT infections

Design outcomes

Primary

Measure	Time frame
Symptomatic ImprovementTimepoint: The baseline and 15th day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Mohammadu Nizar Mohamed Musthaq

National Institute of Unani Medicine

arish_sherwani@yahoo.co.in9448794691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026